Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Ward

Showing results (211-220 of 494) with videos related to

Pageof 50
Sort By:
NPJ Vaccines|March 1, 2022
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimersIván Del Moral-Sánchez, Rebecca A Russell, Edith E Schermer, et al.
Cell Reports|April 14, 2021
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodiesCharles D Murin, Pavlo Gilchuk, Philipp A Ilinykh, et al.
Cell Host & Microbe|November 24, 2019
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in MiceIuliia M Gilchuk, Sandhya Bangaru, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunizationHannah L Turner, Raiees Andrabi, Christopher A Cottrell, et al.
Protein Science : a Publication of the Protein Society|October 18, 2024
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionalityMonica L Fernández-Quintero, Enrico Guarnera, Djordje Musil, et al.
Frontiers in Immunology|August 9, 2024
mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodiesJavier Guenaga, Mehrdad Alirezaei, Yu Feng, et al.
Retrovirology|April 29, 2014
Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studiesNancy P Y Chung, Katie Matthews, Helen J Kim, et al.
Cell|May 18, 2019
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer InterfaceSandhya Bangaru, Shanshan Lang, Michael Schotsaert, et al.
Cell Reports|October 6, 2017
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal ModelJames E Voss, Raiees Andrabi, Laura E McCoy, et al.
Plos Pathogens|February 8, 2021
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infectionTysheena P Charles, Samantha L Burton, Prabhu S Arunachalam, et al.
Pageof 50

Showing results (211-220 of 494) with videos related to

Sort By:
Pageof 50
NPJ Vaccines|March 1, 2022
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimersIván Del Moral-Sánchez, Rebecca A Russell, Edith E Schermer, et al.
Cell Reports|April 14, 2021
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodiesCharles D Murin, Pavlo Gilchuk, Philipp A Ilinykh, et al.
Cell Host & Microbe|November 24, 2019
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in MiceIuliia M Gilchuk, Sandhya Bangaru, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunizationHannah L Turner, Raiees Andrabi, Christopher A Cottrell, et al.
Protein Science : a Publication of the Protein Society|October 18, 2024
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionalityMonica L Fernández-Quintero, Enrico Guarnera, Djordje Musil, et al.
Frontiers in Immunology|August 9, 2024
mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodiesJavier Guenaga, Mehrdad Alirezaei, Yu Feng, et al.
Retrovirology|April 29, 2014
Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studiesNancy P Y Chung, Katie Matthews, Helen J Kim, et al.
Cell|May 18, 2019
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer InterfaceSandhya Bangaru, Shanshan Lang, Michael Schotsaert, et al.
Cell Reports|October 6, 2017
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal ModelJames E Voss, Raiees Andrabi, Laura E McCoy, et al.
Plos Pathogens|February 8, 2021
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infectionTysheena P Charles, Samantha L Burton, Prabhu S Arunachalam, et al.
Pageof 50